Top Markets
#1 Official Trump Official Trump +37.23%
#2 Movement Movement +23.31%
#3 EXOD EXOD +18.93%
#4 Mubarak Mubarak +18.79%
#5 Wrapped POL Wrapped POL +18.77%
#6 POL (ex-MATIC) POL (ex-MATIC) +18.22%
#7 Pearl Pearl +17.85%
#8 Wrapped STX (Velar) Wrapped STX (Velar) +17.55%
#9 Melania Meme Melania Meme +16.90%
#10 Audiera Audiera +11.90%
Coin of the day
Official Trump Official Trump
Settings
Language
ENGLISH
Currency
USD
Theme
HeXun Biosciences Co., Ltd. HeXun Biosciences Co., Ltd.

HeXun Biosciences Co., Ltd.

6986
Rank in Stocks #23611
HeXun Biosciences Co., Ltd., a Taiwanese enterprise, focuses on the research,... HeXun Biosciences Co., Ltd., a Taiwanese enterprise, focuses on the research, development, and application of stem cell technologies and treatments. The company also offers a comprehensive suite of related services, including contract development and manufacturing for various cell types and their derivatives, outsourced production capabilities, quality control inspections, expert consulting, laboratory information management system (LIMS) implementation, and sterile (aseptic) filling solutions. Founded in 2019, its operations are headquartered in Taoyuan City, Taiwan.
Share Price
$1.37
Last synced: 2026-08-21
Market Cap
$71.29M
Change (1 day)
-0.23%
Change (1 year)
-39.17%
Country
TW
Trade HeXun Biosciences Co., Ltd. (6986)

Category

Healthcare
Revenue for HeXun Biosciences Co., Ltd. (6986)
Revenue in Aug 2026 TTM: 0
According to HeXun Biosciences Co., Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for HeXun Biosciences Co., Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH